Basit öğe kaydını göster

dc.contributor.authorBasar, Halil
dc.contributor.authorSelvi, İsmail
dc.date.accessioned2021-12-10T11:31:53Z
dc.date.available2021-12-10T11:31:53Z
dc.date.issued2020
dc.identifier.citationSelvi İ., Basar H., "Subcapsular orchiectomy versus total orchiectomy and LHRH analogue in the treatment of hormone-sensitive metastatic prostate cancer: a different perspective in evaluation of the psychosocial effects", SUPPORTIVE CARE IN CANCER, cilt.28, sa.9, ss.4313-4326, 2020
dc.identifier.issn0941-4355
dc.identifier.othervv_1032021
dc.identifier.otherav_841bdcc7-e35a-4b0c-9c39-4c2ffb5921bd
dc.identifier.urihttp://hdl.handle.net/20.500.12627/172079
dc.identifier.urihttps://doi.org/10.1007/s00520-019-05266-2
dc.description.abstractPurpose We aimed to compare total orchiectomy, subcapsular orchiectomy, and luteinizing hormone-releasing hormone (LHRH) analogue treatment in patients with hormone-sensitive metastatic prostate cancer in terms of efficacy of androgen deprivation treatment (ADT), patient satisfaction, health-related quality of life (HRQoL), development of phantom testis syndrome (PTS), and post-traumatic stress disorder (PTSD). Method Among 272 patients treated between July 2015 and January 2019, 189 patients were enrolled in this prospective, cohort study and the patients were divided into three groups: group I, bilateral total orchiectomy (n66); group II, bilateral subcapsular orchiectomy (n63); and group III, LHRH analogue treatment (n60). The adequacy of ADT was routinely monitored every 3 months and clinical parameters were evaluated. After 6 to 36 months following ADT, questionnaires were used to evaluate PTS, PTSD, and HRQoL during outpatient visits. The patient satisfaction was questioned as yes/no. Results Adequate castration was provided with all three treatments, while the presence and frequency of PTS and severity of PTSD were lower, and patient satisfaction related to ADT and all components of HRQoL were better in patients undergoing subcapsular orchiectomy than those undergoing total orchiectomy. All findings except for PTS were similar in patients undergoing subcapsular orchiectomy and LHRH analogue treatment. In analysis of all patients, total incidence of PTS was 43.4% and PTSD was reported to be 48.7%. A strong relationship was found between PTSD and phantom testis pain (r0.621,p < 0.001). Conclusions Subcapsular orchiectomy has less psychosocial side effects than total orchiectomy and is similar to LHRH analogue treatment. It can be a reliable, cheaper, and fast-acting alternative to LHRH analogue treatment.
dc.language.isoeng
dc.subjectİç Hastalıkları
dc.subjectOnkoloji
dc.subjectHealth Policy
dc.subjectChiropractics
dc.subjectHealth Information Management
dc.subjectLeadership and Management
dc.subjectReview and Exam Preparation
dc.subjectRehabilitation
dc.subjectOncology
dc.subjectPhysical Therapy, Sports Therapy and Rehabilitation
dc.subjectMedical Terminology
dc.subjectMedical Assisting and Transcription
dc.subjectCommunity and Home Care
dc.subjectCare Planning
dc.subjectHealth Professions (miscellaneous)
dc.subjectHealth Sciences
dc.subjectONKOLOJİ
dc.subjectKlinik Tıp
dc.subjectKlinik Tıp (MED)
dc.subjectSAĞLIK BAKIM BİLİMLERİ VE HİZMETLERİ
dc.subjectREHABİLİTASYON
dc.subjectTıp
dc.subjectSağlık Bilimleri
dc.subjectDahili Tıp Bilimleri
dc.subjectAile Hekimliği
dc.subjectFiziksel Tıp ve Rehabilitasyon
dc.titleSubcapsular orchiectomy versus total orchiectomy and LHRH analogue in the treatment of hormone-sensitive metastatic prostate cancer: a different perspective in evaluation of the psychosocial effects
dc.typeMakale
dc.relation.journalSUPPORTIVE CARE IN CANCER
dc.contributor.departmentKarabük Üniversitesi , ,
dc.identifier.volume28
dc.identifier.issue9
dc.identifier.startpage4313
dc.identifier.endpage4326
dc.contributor.firstauthorID2696710


Bu öğenin dosyaları:

DosyalarBoyutBiçimGöster

Bu öğe ile ilişkili dosya yok.

Bu öğe aşağıdaki koleksiyon(lar)da görünmektedir.

Basit öğe kaydını göster